Literature DB >> 2910614

Preoperative embolization in the treatment of osseous metastases from renal cell carcinoma.

M W Roscoe1, R J McBroom, E St Louis, H Grossman, R Perrin.   

Abstract

Metastatic lesions due to renal cell carcinoma are frequently hypervascular. This study reports the results of preoperative embolization of skeletal metastases from hypernephroma. Reported for the first time in the English literature is the use of this technique for preoperative devascularization of metastatic lesions to the spine in eight patients. Effective devascularization was achieved in all peripheral lesions. Blood loss for peripheral lesions averaged 940 cc and compared favorably to 20 nonembolized cases, in whom average blood loss was 1975 cc. Spinal embolization requires careful identification and preservation of any segmental arteries that supply the anterior spinal artery. Effective spinal devascularization was achieved in six of eight patients. In two patients significant bleeding occurred as a result of incomplete embolization. This series supports the growing evidence for the efficacy and safety of selective arterial embolization in the preoperative control of hemostasis in patients with metastatic hypernephroma. Embolization of spinal metastases, although technically demanding, has been effective in devascularizing these lesions without serious neurologic complications.

Entities:  

Mesh:

Year:  1989        PMID: 2910614

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?

Authors:  Zhihong Qiao; Ningyang Jia; Qian He
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

2.  Preoperative embolization.

Authors:  William S Rilling; Gene W Chen
Journal:  Semin Intervent Radiol       Date:  2004-03       Impact factor: 1.513

3.  The role of preoperative vascular embolization in surgery for metastatic spinal tumours.

Authors:  Naresh Kumar; Barry Tan; Aye Sandar Zaw; Hnin Ei Khine; Karthikeyan Maharajan; Leok Lim Lau; Prapul Chander Rajendran; Anil Gopinathan
Journal:  Eur Spine J       Date:  2016-03-11       Impact factor: 3.134

4.  Embolisation of bone metastases from renal cancer.

Authors:  G Rossi; A F Mavrogenis; R Casadei; G Bianchi; C Romagnoli; E Rimondi; P Ruggieri
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

5.  Not All Patients Undergoing Stabilization of Impending Pathologic Fractures for Renal Cell Carcinoma Metastases to the Femur Need Preoperative Embolization.

Authors:  Edward W Jernigan; Joshua N Tennant; Robert J Esther
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

6.  Preoperative embolization of cervical spine osteoblastomas: report of three cases.

Authors:  J Trübenbach; T Nägele; T Bauer; U Ernemann
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

7.  Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss.

Authors:  C Manke; T Bretschneider; M Lenhart; M Strotzer; C Neumann; J Gmeinwieser; S Feuerbach
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

8.  Embolization of hypervascular bone metastases reduces intraoperative blood loss: a case-control study.

Authors:  Theresa J C Pazionis; Ioannis D Papanastassiou; Majid Maybody; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2014-06-26       Impact factor: 4.176

9.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

10.  A new dorsal modular fixation device allows a modified approach in cervical and cervico-thoracic neoplastic lesions.

Authors:  K Huch; B Cakir; K Dreinhöfer; W Puhl; M Richter
Journal:  Eur Spine J       Date:  2004-01-20       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.